Evidence map›Paper›PMID 40534141›Full record

ArticleJournal of the International AIDS Society2025

Factors associated with awareness of and willingness to use PrEP among stable, heterosexual HIV-serodifferent couples in seven African countries, 2019-2022.

J Danielle Sharpe, Rebecca L Laws, Christine A West, Gaston Djomand, Jared Omolo, Dinah Ramaabya, Michelle Li, Sindisiwe Dlamini, Maletsatsi Motebang, Nthuseng Marake and 13 more

Abstract read
In one paragraph

Article in Journal of the International AIDS Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

J Danielle SharpeDivision of Global HIV and TB, US Centers for Disease Control and Prevention, Atlanta, Georgia, USA.ORCID https://orcid.org/0000-0003-1898-6202
Rebecca L LawsDivision of Global HIV and TB, US Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Christine A WestDivision of Global HIV and TB, US Centers for Disease Control and Prevention, Atlanta, Georgia, USA.ORCID https://orcid.org/0000-0003-1102-9602
Gaston DjomandDivision of Global HIV and TB, US Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Jared OmoloDivision of Global HIV and TB, US Centers for Disease Control and Prevention, Gaborone, Botswana.
Dinah RamaabyaMinistry of Health, Gaborone, Botswana.
Michelle LiDivision of Global HIV and TB, US Centers for Disease Control and Prevention, Mbabane, Eswatini.
Sindisiwe DlaminiMinistry of Health, Mbabane, Eswatini.
Maletsatsi MotebangDivision of Global HIV and TB, US Centers for Disease Control and Prevention, Maseru, Lesotho.
Nthuseng MarakeMinistry of Health, Maseru, Lesotho.
Victor SinganoDivision of Global HIV and TB, US Centers for Disease Control and Prevention, Lilongwe, Malawi.
Washington OzituosaukaMinistry of Health, Lilongwe, Malawi.
Carter McCabeDivision of Global HIV and TB, US Centers for Disease Control and Prevention, Maputo, Mozambique.ORCID https://orcid.org/0000-0002-0002-3654
Isabel SathaneMinistry of Health, Maputo, Mozambique.
Nzali KancheyaDivision of Global HIV and TB, US Centers for Disease Control and Prevention, Lusaka, Zambia.
Tina ChisengaMinistry of Health, Lusaka, Zambia.
Rickie MalabaDivision of Global HIV and TB, US Centers for Disease Control and Prevention, Harare, Zimbabwe.
Getrude NcubeMinistry of Health and Child Care, Harare, Zimbabwe.
Neena M PhilipICAP at Columbia University, New York, New York, USA.
Samuel BiraroICAP at Columbia University, Kampala, Uganda.
Man E CharuratCenter for International Health, Education, and Biosecurity, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Italia RolleDivision of Global HIV and TB, US Centers for Disease Control and Prevention, Atlanta, Georgia, USA.ORCID https://orcid.org/0000-0003-1331-0553
Andrew C VoetschDivision of Global HIV and TB, US Centers for Disease Control and Prevention, Atlanta, Georgia, USA.ORCID https://orcid.org/0000-0002-0783-1312

Funding

PEPFAR #U2GGH002172PEPFAR #U2GGH002173
6 · The paper itself

Abstract

introductionHIV pre-exposure prophylaxis (PrEP) is an effective biomedical intervention for preventing HIV; however, PrEP adoption initially lagged across sub-Saharan Africa (SSA) and may have been affected by barriers to engagement in PrEP care. Stable, heterosexual HIV-serodifferent couples are a priority population of PrEP expansion efforts. We assessed factors associated with PrEP awareness and willingness among HIV-serodifferent couples in SSA to guide PrEP interventions for this population.

methodsWe conducted a cross-sectional analysis using pooled data from nationally representative, two-stage cluster sampling, HIV-focused household surveys completed during 2019-2022 in seven African countries. We analysed data from 1738 persons without HIV aged ≥15 years in stable, heterosexual HIV-serodifferent couples and included clinical information from their partners with HIV. Higher HIV risk was defined by unawareness of a partner's HIV-positive status or having a partner with an unsuppressed viral load (≥200 copies/ml). Lower HIV risk was defined by awareness of a partner's HIV-positive status and having a partner with a suppressed viral load (<200 copies/ml). We conducted multivariable logistic regression using survey weights and jackknife variance estimation to assess factors associated with PrEP awareness and willingness.

resultsOverall, 18.1% were aware of PrEP, 69.1% were willing to use PrEP and 5.1% had ever used PrEP. Forty-four percent had higher HIV risk. Higher odds of PrEP awareness were associated with being female (adjusted odds ratio [aOR]: 1.73; 95% confidence interval [CI]: 1.15-2.59), secondary education or higher (aOR: 6.42; 95% CI: 2.97-13.91) and lower HIV risk (aOR: 1.58; 95% CI: 1.00-2.48). Higher odds of PrEP willingness were associated with employment in the past year (aOR: 1.55; 95% CI: 1.01-2.37), previous PrEP awareness (aOR: 2.44; 95% CI: 1.36-4.36) and lower HIV risk (aOR: 1.70; 95% CI: 1.07-2.70).

conclusionsPersons in stable, heterosexual HIV-serodifferent couples with lower HIV risk were more aware of and willing to use PrEP than those with higher risk. Our findings highlight the importance of encouraging HIV status disclosure, educating about HIV-serodifference and PrEP, and providing PrEP linkage during HIV testing and prevention counselling to increase PrEP awareness, willingness and use among HIV-serodifferent couples in SSA.

Indexed as

Anti-HIV AgentsHealth Knowledge, Attitudes, PracticeHeterosexualityHIV InfectionsPatient Acceptance of Health CarePre-Exposure ProphylaxisSexual PartnersAdolescentAdultAfricaAfrica South of the SaharaCross-Sectional StudiesFemaleHumansMaleMiddle AgedAnti-HIV AgentsAfricaHIVHIV‐serodifferent couplesPopulation‐based HIV Impact Assessmentpre‐exposure prophylaxis

Identifiers

PMID40534141
PMCPMC12177106

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.